Roche's Tecentriq meets targets in lung cancer trial

ZURICH (Reuters) - A combination of Roche's Tecentriq immunotherapy with chemotherapy helped people with a form of lung cancer live significantly longer than patients on chemotherapy alone, a late-stage trial cited by the Swiss drugmaker showed.

Alibaba injects pharmacy assets into healthcare unit in $1.4 billion deal

SHANGHAI (Reuters) - Chinese e-commerce giant Alibaba Group Holding Ltd will inject some of its online pharmacy business into a listed unit in a deal valued at HK$10.6 billion ($1.35 billion), the firm said in a statement on Tuesday.

WHO's Congo Ebola plan assumes 100-300 cases over three months

GENEVA (Reuters) - The World Health Organization said it was assuming 100-300 cases of Ebola in Democratic Republic of Congo over a three-month timeline, under a revised strategic response plan it published on Tuesday.

Northern Ireland rally calls on Britain's May to ease abortion rules

BELFAST (Reuters) - Hundreds of women's rights activist rallied in Belfast on Monday to put pressure on British Prime Minister Theresa May to reform Northern Ireland's highly restrictive abortion rules after neighboring Ireland's vote to liberalize its laws.

Teen mothers in foster care have high risk of losing custody of babies

(Reuters Health) - Teen mothers who are in foster care may be more likely to lose custody of their babies than adolescent mothers in different living circumstances, a Canadian study suggests.

U.S. doctors call for health policies that support women

(Reuters Health) - Making it easier and more affordable for women to access care, and supporting research that includes how treatments work in both sexes, can improve the health of all Americans, not just women, U.S. doctors argue.

India steps up hunt for origin of mysterious brain-damaging virus

MUMBAI/KOCHI (Reuters) - India began a fresh round of tests to trace the origin of a rare brain-damaging virus that has killed 13 people, a health official said on Monday, as initial tests on animals suspected of carrying the Nipah virus showed no sign of the disease.

New Zealand to spend $600 million to eradicate cattle disease

WELLINGTON (Reuters) - New Zealand, the world's biggest dairy exporter, will spend more than NZ$880 million ($610 million) in a bid to eradicate the mycoplasma bovis cattle disease, Prime Minister Jacinda Ardern said on Monday.

U.S. jury fails to reach verdict in latest J&J talc trial

NEW YORK (Reuters) - A South Carolina jury on Friday could not agree on a verdict in a case of a woman whose family said her long-term use of Johnson & Johnson's Baby Powder led to her death from asbestos-related cancer, resulting in a mistrial.

Fear and suspicion hinder Congo medics in Ebola battle

DAKAR (Reuters) - With more than twice as many Ebola outbreaks as any other country since the virus was discovered in 1976, Congolese are familiar with its destructive power, yet fear and suspicion of medical authorities are still hindering efforts at containment.

Related Videos

Slovene beekeepers hope to have a stinging impact on bee preservation

Aquatic moss that removes arsenic from water discovered

You might like...

Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.

Subscribe here